Results
|
25241.
|
|
|
25242.
|
Tumor-cell number and viability as quality and efficacy parameters of autologous virus-modified cancer vaccines in patients with breast or ovarian cancer. [electronic resource] by
- Ahlert, T
- Sauerbrei, W
- Bastert, G
- Ruhland, S
- Bartik, B
- Simiantonaki, N
- Schumacher, J
- Häcker, B
- Schumacher, M
- Schirrmacher, V
Producer: 19970710
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 15
Availability: No items available.
|
|
25243.
|
|
|
25244.
|
|
|
25245.
|
|
|
25246.
|
|
|
25247.
|
|
|
25248.
|
|
|
25249.
|
|
|
25250.
|
|
|
25251.
|
|
|
25252.
|
|
|
25253.
|
|
|
25254.
|
Evaluation of the safety, immunogenicity, and protective efficacy of whole inactivated simian immunodeficiency virus (SIV) vaccines with conformationally and functionally intact envelope glycoproteins. [electronic resource] by
- Lifson, Jeffrey D
- Rossio, Jeffrey L
- Piatak, Michael
- Bess, Julian
- Chertova, Elena
- Schneider, Douglas K
- Coalter, Vicky J
- Poore, Barbara
- Kiser, Rebecca F
- Imming, Robert J
- Scarzello, Anthony J
- Henderson, Louis E
- Alvord, W Gregory
- Hirsch, Vanessa M
- Benveniste, Raoul E
- Arthur, Larry O
Producer: 20040915
In:
AIDS research and human retroviruses vol. 20
Availability: No items available.
|
|
25255.
|
|
|
25256.
|
|
|
25257.
|
|
|
25258.
|
|
|
25259.
|
|
|
25260.
|
|